C9orf72-linked arginine-rich dipeptide repeats aggravate pathological phase separation of G3BP1

Proc Natl Acad Sci U S A. 2024 Dec 10;121(50):e2402847121. doi: 10.1073/pnas.2402847121. Epub 2024 Dec 2.

Abstract

The toxic effects of C9orf72-derived arginine-rich dipeptide repeats (R-DPRs) on cellular stress granules in amyotrophic lateral sclerosis (ALS) and frontotemporal dementia remain unclear at the molecular level. Stress granules are formed through the switch of Ras GTPase-activating protein-binding protein 1 (G3BP1) by RNA from a closed inactive state to an open activated state, driving the formation of the organelle by liquid-liquid phase separation (LLPS). We show that R-DPRs bind G3BP1 a thousand times stronger than RNA and initiate LLPS much more effectively. Their pathogenic effect is underscored by the slow transition of R-DPR-G3BP1 droplets to aggregated, ThS-positive states that can recruit ALS-linked proteins hnRNPA1, hnRNPA2, and TDP-43. Deletion constructs and molecular simulations show that R-DPR binding and LLPS are mediated via the negatively charged intrinsically disordered region 1 (IDR1) of the protein, allosterically regulated by its positively charged IDR3. Bioinformatic analyses point to the strong mechanistic parallels of these effects with the interaction of R-DPRs with nucleolar nucleophosmin 1 (NPM1) and underscore that R-DPRs interact with many other similar nucleolar and stress-granule proteins, extending the underlying mechanism of R-DPR toxicity in cells. Our results also highlight characteristic differences between the two R-DPRs, poly-GR and poly-PR, and suggest that the primary pathological target of poly-GR is not NPM1 in nucleoli, but G3BP1 in stress granules in affected cells.

Keywords: G3BP1; liquid–liquid phase separation; neurodegenerative disease; repeat-expansion disease; stress granules.

MeSH terms

  • Amyotrophic Lateral Sclerosis* / genetics
  • Amyotrophic Lateral Sclerosis* / metabolism
  • Arginine* / chemistry
  • Arginine* / metabolism
  • C9orf72 Protein* / genetics
  • C9orf72 Protein* / metabolism
  • DNA Helicases* / genetics
  • DNA Helicases* / metabolism
  • DNA-Binding Proteins / chemistry
  • DNA-Binding Proteins / genetics
  • DNA-Binding Proteins / metabolism
  • Dipeptides* / chemistry
  • Dipeptides* / metabolism
  • Frontotemporal Dementia / genetics
  • Frontotemporal Dementia / metabolism
  • Frontotemporal Dementia / pathology
  • Heterogeneous Nuclear Ribonucleoprotein A1 / genetics
  • Heterogeneous Nuclear Ribonucleoprotein A1 / metabolism
  • Humans
  • Nucleophosmin* / genetics
  • Phase Separation
  • Poly-ADP-Ribose Binding Proteins* / chemistry
  • Poly-ADP-Ribose Binding Proteins* / genetics
  • Poly-ADP-Ribose Binding Proteins* / metabolism
  • Protein Binding
  • RNA Helicases* / genetics
  • RNA Helicases* / metabolism
  • RNA Recognition Motif Proteins* / chemistry
  • RNA Recognition Motif Proteins* / genetics
  • RNA Recognition Motif Proteins* / metabolism
  • Stress Granules / metabolism

Substances

  • G3BP1 protein, human
  • RNA Recognition Motif Proteins
  • Poly-ADP-Ribose Binding Proteins
  • C9orf72 Protein
  • RNA Helicases
  • Dipeptides
  • DNA Helicases
  • Arginine
  • Nucleophosmin
  • C9orf72 protein, human
  • NPM1 protein, human
  • DNA-Binding Proteins
  • hnRNPA1 protein, human
  • Heterogeneous Nuclear Ribonucleoprotein A1
  • TARDBP protein, human